Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Kestra Medical Techs (NASDAQ:KMTS) raises FY2026 sales outlook from $85.000 million to $88.000 million vs $85.074 million estim...
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of ...
Wells Fargo analyst Larry Biegelsen maintains Kestra Medical Techs (NASDAQ:KMTS) with a Overweight and lowers the price targ...
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.15) per share which missed the analyst consensus estimate o...
Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $85.000M vs $82.972M Est
Kestra Medical Techs (NASDAQ: KMTS) sees FY2026 sales of $85.000 million vs $82.972 million analyst estimate.
